These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 30877273)

  • 1. Uterine and vaginal sarcomas resembling fibrosarcoma: a clinicopathological and molecular analysis of 13 cases showing common NTRK-rearrangements and the description of a COL1A1-PDGFB fusion novel to uterine neoplasms.
    Croce S; Hostein I; Longacre TA; Mills AM; Pérot G; Devouassoux-Shisheboran M; Velasco V; Floquet A; Guyon F; Chakiba C; Querleu D; Khalifa E; Mayeur L; Rebier F; Leguellec S; Soubeyran I; McCluggage WG
    Mod Pathol; 2019 Jul; 32(7):1008-1022. PubMed ID: 30877273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COL1A1-PDGFB Fusion Associated Fibrosarcoma of the Uterine Corpus: A Case Report and Literature Review.
    Panwar V; Liu Y; Gwin K; Chen H
    Int J Gynecol Pathol; 2023 Mar; 42(2):143-146. PubMed ID: 36729934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NTRK Fusions Define a Novel Uterine Sarcoma Subtype With Features of Fibrosarcoma.
    Chiang S; Cotzia P; Hyman DM; Drilon A; Tap WD; Zhang L; Hechtman JF; Frosina D; Jungbluth AA; Murali R; Park KJ; Soslow RA; Oliva E; Iafrate AJ; Benayed R; Ladanyi M; Antonescu CR
    Am J Surg Pathol; 2018 Jun; 42(6):791-798. PubMed ID: 29553955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COL1A1::PDGFB fusion-associated uterine fibrosarcoma: A case report and review of the literature.
    Rota S; Franza A; Fabbroni C; Paolini B; Greco FG; Alessi A; Padovano B; Casali P; Sanfilippo R
    Cancer Rep (Hoboken); 2024 Feb; 7(2):e1969. PubMed ID: 38279510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COL1A1::PDGFB fusion uterine sarcoma with a TERT promoter mutation.
    Lu Y; Chen X; Zeng W; Hua P; Shen Y; Qiu Y; He X; Zhang H
    Genes Chromosomes Cancer; 2024 Jan; 63(1):e23210. PubMed ID: 37870859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NTRK fusion cervical sarcoma: a report of three cases, emphasising morphological and immunohistochemical distinction from other uterine sarcomas, including adenosarcoma.
    Rabban JT; Devine WP; Sangoi AR; Poder L; Alvarez E; Davis JL; Rudzinski E; Garg K; Bean GR
    Histopathology; 2020 Jul; 77(1):100-111. PubMed ID: 31971278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uterine sarcomas and rare uterine mesenchymal tumors with malignant potential. Diagnostic guidelines of the French Sarcoma Group and the Rare Gynecological Tumors Group.
    Croce S; Devouassoux-Shisheboran M; Pautier P; Ray-Coquard I; Treilleux I; Neuville A; Arnould L; Just PA; Belda MALF; Averous G; Leroux A; Mery E; Loussouarn D; Weinbreck N; Le Guellec S; Mishellany F; Morice P; Guyon F; Genestie C
    Gynecol Oncol; 2022 Nov; 167(2):373-389. PubMed ID: 36114030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pan-TRK immunohistochemistry in gynaecological mesenchymal tumours: diagnostic implications and pitfalls.
    Moura MS; Costa J; Velasco V; Kommoss F; Oliva E; Le Loarer F; McCluggage WG; Razack R; Treilleux I; Mills A; Longacre T; Devouassoux-Shisheboran M; Hostein I; Azmani R; Blanchard L; Hartog C; Soubeyran I; Khalifa E; Croce S
    Histopathology; 2024 Feb; 84(3):451-462. PubMed ID: 37988282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NTRK and other recently described kinase fusion positive uterine sarcomas: A review of a group of rare neoplasms.
    Croce S; Hostein I; McCluggage WG
    Genes Chromosomes Cancer; 2021 Mar; 60(3):147-159. PubMed ID: 33099837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uterine Sarcoma With EML4::NTRK3 Fusion: A Spectrum of Mesenchymal Neoplasms Harboring Actionable Gene Fusions.
    de Castro JVA; Dos Santos PJS; Mantoan H; Baiocchi G; Bovolim G; Torrezan G; Corassa M; do Nascimento AG; De Brot M; Costa FD; De Brot L
    Int J Gynecol Pathol; 2024 Jan; 43(1):56-60. PubMed ID: 37668341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis of uterine sarcomas and rare uterine mesenchymal tumours with malignant potential. Guidelines of the French Sarcoma Group and Rare Gynaecological Tumours].
    Croce S; Devouassoux-Shisheboran M; Pautier P; Ray-Coquard I; Treilleux I; Neuville A; Arnould L; Just PA; Le Frere Belda MA; Averous G; Leroux A; Bataillon G; Mery E; Loussouarn D; Weinbreck N; Le Guellec S; Mishellany F; Morice P; Guyon F; Genestie C
    Bull Cancer; 2024 Jan; 111(1):97-116. PubMed ID: 37806863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uterine mesenchymal tumours: recent advances.
    Momeni-Boroujeni A; Chiang S
    Histopathology; 2020 Jan; 76(1):64-75. PubMed ID: 31846533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cryptic COL1A1-PDGFB fusion in dermatofibrosarcoma protuberans: a clinicopathological and genetic analysis].
    Chen M; Chen YM; Lu Y; He X; Peng H; Zhang HY
    Zhonghua Bing Li Xue Za Zhi; 2023 Jan; 52(1):13-18. PubMed ID: 36617900
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinicopathological findings of pediatric NTRK fusion mesenchymal tumors.
    Kang J; Park JW; Won JK; Bae JM; Koh J; Yim J; Yun H; Kim SK; Choi JY; Kang HJ; Kim WS; Shin JH; Park SH
    Diagn Pathol; 2020 Sep; 15(1):114. PubMed ID: 32957984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TMP3-NTRK1 rearranged uterine sarcoma: A case report.
    Boyle W; Williams A; Sundar S; Yap J; Taniere P; Rehal P; Ganesan R
    Case Rep Womens Health; 2020 Oct; 28():e00246. PubMed ID: 32939344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of COL1A1-PDGFB breakpoints by next-generation sequencing in the molecular diagnosis of dermatofibrosarcoma protuberans.
    Zhu R; Yan J; Li B; Tan F; Yan W; Shen J; Fan L; Ding L; Chen Y; Tang Y; Liu Y; Bai Y
    Exp Mol Pathol; 2021 Oct; 122():104672. PubMed ID: 34371012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Characterization of Dermatofibrosarcoma Protuberans: The Clinicopathologic Significance of Uncommon Fusion Gene Rearrangements and Their Diagnostic Importance in the Exclusively Subcutaneous and Circumscribed Lesions.
    Lee PH; Huang SC; Wu PS; Tai HC; Lee CH; Lee JC; Kao YC; Tsai JW; Hsieh TH; Li CF; Li WS; Liu TT; Su YL; Yu SC; Huang HY
    Am J Surg Pathol; 2022 Jul; 46(7):942-955. PubMed ID: 35034038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative PDGFD rearrangements in dermatofibrosarcomas protuberans without PDGFB fusions.
    Dadone-Montaudié B; Alberti L; Duc A; Delespaul L; Lesluyes T; Pérot G; Lançon A; Paindavoine S; Di Mauro I; Blay JY; de la Fouchardière A; Chibon F; Karanian M; MacGrogan G; Kubiniek V; Keslair F; Cardot-Leccia N; Michot A; Perrin V; Zekri Y; Coindre JM; Tirode F; Pedeutour F; Ranchère-Vince D; Le Loarer F; Pissaloux D
    Mod Pathol; 2018 Nov; 31(11):1683-1693. PubMed ID: 29955147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTRK -Rearranged Uterine Sarcomas: Clinicopathologic Features of 15 Cases, Literature Review, and Risk Stratification.
    Costigan DC; Nucci MR; Dickson BC; Chang MC; Song S; Sholl LM; Hornick JL; Fletcher CDM; Kolin DL
    Am J Surg Pathol; 2022 Oct; 46(10):1415-1429. PubMed ID: 35713627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal tumors of the gastrointestinal tract with NTRK rearrangements: a clinicopathological, immunophenotypic, and molecular study of eight cases, emphasizing their distinction from gastrointestinal stromal tumor (GIST).
    Atiq MA; Davis JL; Hornick JL; Dickson BC; Fletcher CDM; Fletcher JA; Folpe AL; Mariño-Enríquez A
    Mod Pathol; 2021 Jan; 34(1):95-103. PubMed ID: 32669612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.